Four sets of glycolipid variante of human A and 0 erythrocytes were isolated and their structures were determined. The glycolipids carrying A-determinants were termed Aa, Ab, AC and Ad according to the complexity of the carrier carbohydrate chain. in that order. Glycolipids with H-activity were termed H1, ~. H3 and H4 according to the order of their complexity of the carrier carbohydrate chain. It is suggested that the conversion of complex H variante (H3/or H4) to complex A variante (AC/or Ad) was significantly lower in A2 erythrocytes. In fetal/er new-born erythrocytes the highly complex variante (Ac, Ad, H3 and H4) were significantly lower • than adult erythrocytes. These and other studies suggest that step-by-step elongation and arborization of complex glycolipids such as Ac and H3 chains may take place during the process of development. A remarkable difference between the reaction of glycolipids in human intestinal tumors and the reaction of normal intestinal mucosa was demonstrated by the antibody which was directed against core structure of carrier carbohydrate chain, that is GlcNAcßl~3Galßl~4Glc~er. This structure must be present in greater quantity in ~umor tissue than in normal mucosa.
INTRODUCTION
Although already early in the century, blood group activities were found tobe associated with the lipid extract of erythrocytes (for a review, see Ref. 1}, the idea of blood group glycolipid antigens waited over fifty years for a few investigators who found the presence of a lipid-bound carbohydrate containing neutral and aminosugars with blood group activity (Ref. 2, 3, 4, 5) . Yamakawa et al (Ref. 6) described that a globoside fraction of human erythrocytes was blood group active,but subsequent studies indicated that the activities were associated with an unidentified glycolipid, which was separated from the major globoside fraction through chromatography (Ref. 7, 8, 9) . It was noteworthy that a small, but measurable amount of fucose, was detected in this blood group active glycolipid fraction (Yamakawa and Irie, Ref. 7) . Blood group A-and B-active glycolipids with a similar chemical composition were isolated subsequently by Koscielak (Ref. 10) and by Handa (Ref. 11) . These preparations must have been grossly contaminated by gangliosides and other unidentified glycolipids in view of our present day criteria.
The presence of fucose as an essential component for a blood group active glycolipid was revealed later on through a different avenue of approach. The author found a unique fucosylglycosphingolipid present in a relatively large quantity in some human adenocardinomas of the stomach and colon (Ref. 12) • The glycolipid was H-acti ve as well as Lea._acti ve ( Hakomori et al Ref. 13) . The presence of a fucolipid and the demonstration of H-and 1ea-activity in the fucose-glycolipid, prompted us to search further into fucose glycolipids as a possible blood group antigen of erythrocytes, because at that time the specific structural relationship between blood group A, B, and H/or Lewis activities was already established by studies of Watkins and Morgan (Ref, 14) and by Cepellini (Ref. 15 ). This approachwas further encouraged by an observation made by Schiffman et al (Ref, 16) and Lloyd and Kabat (Ref. 17) i.e.: fucose containing oligosaccharide asbeing the best hapten showing a high activity-of blood group A and B, and that the presence of fucose was considered to be essential for the blood group hapten activity, Consequently, a thorough fractionation and purification of blood group ABH glycolipids were carried out when the author was at Brandeis University (Hakomori and Strycharz, Ref, 18) , Only a very small quanti ty of seemingly pure glycolipids wi th a high A and B activity was isolated through successive chromatographies. These highly purified This investigation is supported by the National Institute of Health Grants CA 19224, GM 23100, American Cancer Society BC-9F and National Cancer Institutes Contract NOl-CB-43920. ~esent address, Department of Biochemistry, University of Kentucky, Lexington, KY, 40506.
antigens were characterized by the presence of a high content of fucose and demonstrated a noticeable polymorphism (Ref, 18) , Three active components were isolated from Al-erythrocytes, one of which was lacking in A2-erythrocytes. The simplest component was assumed to be a ceramide hexasaccharide having a similar back-bone structure to a ceramide pentasaccharide which was isolated from H-active or Lewis The major glycolipid of human erythrocyte membranes is.globoside and its precursors: ceramide trihexoside, lactosylceramide, and glucosylceramide. The structures of these glycolipids have been well established as seen in Table 2 . All the blood group ABH glycolipids found in erythrocyte membranes have been characterized by having the common carbohydrate residue, ß-galactosyl(l-+4)ß-N-acetylglucosaminyl(l-+3)ß-galactosyl(l-+4)ß-glucosylceramide ("paragloboside"). Aseries of glycolipids with blood group A and H activities as seen in Table 3 and 4, were isolated and characterized which can be regarded as the derivative of "paragloboside". In contrast, Lea-and Leb-glycolipids are considered to be a derivative of lacto-N-tetraosylceramide rather than a derivative of lacto-N-neotetraosylceramide. This may be related to the fact that Lewis-active glycolipids of erythrocytes were acquired exogenously but were not synthesized in erythorcytes (Marcus and Cass, Ref. 19 ). 1) A-g1ycolipids Four tYPes of blood group A-active glycolipids, Aa, Ab, AC and Ad have been separated through chromatography with either DEAE-cellulose or Anasil S (a mixture of magnesium oxide and silicic acid, Analab Co., Conn.). These A-variants differ in their carrier carbohydrate structure, but the structure of A-determinants is identical among themselves (Ha.komori et ·al, Ref. 21).
----(a) Aa-glycolipids: This component was isolated from other glycolipids such as H1-, Leaglycolipids and 11 paragloboside 11 through thin-la:yer chromatography as acetylated compounds ·and was identified as ceramide hexasaccharide. The compound was hydrolyzed by a-N-acetylgalactosaminidase of Chalonia ~ and was converted to H1-glycolipid. On the other hand, H1-glycolipid can be converted to Aa-glycolipid through serum N-acetylgalactosaminyltransferase and UDP-GalNAc. The structure was further assessed by methylation studies (Watanabe, Stellner and Ha.komori, unpublished observation). Through systematic degradation and methylation analysis, the structure of this glycolipid was determined as seen in Table 3 .
(b) Ab-glycolipids: This component was eluted from a DEAE-cellulose column using solvent numbers 7 and 8 (see Note a), and was further purified through thin-layer chromatography or through a chromatography on a long column of silicic acid ( "Biosil A") wi th a chloroformmethanol-water system. The glycolipid was finally purified as acetylated compound through thin-la:yer chromatography. Ab-glycolipids were converted to H2-glycollpid through Chalonia ~ a-N-acetylgalactosaminidase and H2-glycolipid were converted to Ab-glycolipids by incubation with UDP-GalNAc and serum a-N-acetylgalactosaminyltransferase, and the product was chromatographically indistinguishable from Ab-glycoliplds, on chromatography on silicic acid thin-la:yer and on silica gel-impregnated paper (Watanabe, Stellner and Ha.komori, unpublished observation). These results indicate that Ab-glycolipids must be a ceramide octasaccharide with a structure as shown in Table 3 . (c) AC-glycolipids were eluted from a DEAE-cellulose column using solvent numbers 9 and 10 and partially solvent number 11 (see Note a). The glycolipid was further purified on a long column of silica gel ("Biosil A:) with chloroform-methanol-water system and finally purified as acetylated compound through thin-layer chromatography on silica gel H. This compound was converted through a-N-acetylhexosaminidase of Chalonia lampus (see Note b) to a substance which was indistinguishable from H~-glycolipids. Methylation studies indicated that the branching structure of AC-glycolip1ds could be analogaus to the one as was established in H3-glycolipid, There are two possibilities for the branching structure, namely, a) two identical A-determinants (GalNAcl+3[L-~cl+2]Gall+R) are linked to the type 2 chains which are further linked to paragloboside, b) the secend possibility is that one of the type 2 chain structures mP-Y be jncompleted and devoid of A-determinant, but H-determinant or its pre· cursor form is present at the terminal of one of the branches. These two possibilities were studied by mass spectrometry of permethylated AC compound. The mass #228 (260-32) is the major and the absence of the mass numbers 393 or 219 could exclude the secend possibility as described above. Their terminal non-reducing structures, therefore, must be both substituted with a-N-acetylhexosamine residue, since no terminal galactose was detected through mass spectrometry of fully methylated AC-glycolipids.
The presence of the fourth component of A-active glycolipids (Ad-glycolipid) has been noticed although the fraction was extremely difficult to fUrther purify by the present technique and the chemical structure of this glycolipid has not been elucidated. The fraction is still heterogenaus and fUrther purification has to be made. This fraction contained branching structures as evidenced through methylation studies. 
GalNAca.l~ ~~Galßl~4GlcNAcßl~3Galßl~4Glc+ceramide
GalNAca.l/ .
Similar to Ac, but with an additional branching structure, exact structure undetermined. (a) H1-glycolipid was ~luted from an Anasil S column with solvent numbers 5-7, and with solvent number 6 fram a DEAE-cellulose column (see Note a), . H1 camponent was coeluted with many other glycolipids such as paraglobosides, Lea-, Leb-glycolipids, and ß-galactosyl-paraglobosides (Stellner and Hakamori, Ref. 29) . These camponents were separated from one another on a long column of silica gel using the chloroform-methanol-water system or thin-layer chromatography as acetylated campound. Based on enzymatic degradation, partial acid hydrolysis, and methylation studies, the structure of H1-glycolipid was established as L-fucosyl-~2paragloboside as shown in Table 5 . The major fatty acidwas identified as C20 and the long-chain base exclusively as ClB (octadecasphingenine).
(b) H2-glycolipids: This camponent was eluted using solvent number 9 from "Anasil S" column, and solvent number 7 and 8 fram a DEAE-cellulose column (see Note a). Sequential hydrolysis using various glycosyl hydrolases, as well as methylation analysis established the structure of H2-glycolipids as seen in Table 3 . The H2-glycolipids were not hydrolyzed through endo-ß-N-acetylglucosaminidase (Tarentino et al Ref. 30) , excluding the possibility of such a linkage as a di-N-acetylchitobiosyl structure within the H2-carbohydrate chain.
(c) H3-glycolipids: Incubating H3-glycolipids with a.-L-fucosidase of Chalonia lampus turned the chromatography migration rate of H3-glycolipids to a substance with a slightly higher chromatography migrationrate than that of the original H3-glycolipids. Neither ß-galactosiadase,a.-galactosiadase, nor ß-N-acetylglucosaminidase altered the properties of the H3-glycolipid, The hydrolysis product of H3-glycolipid was then hydrolyzed with Jack bean ß-galactosidase to a substance which had a slightly higher mobility than H 2 -glycolipid. The compound was further degraded using ß-hexosaminidase, resulting in a degradation product identical to paraglobosides in chromatography and in its immunological property. The paragloboside-like material was further identified through successive hydrolysis with ß-galacto·siadase and ß-N-acetylhexosaminidase, H 3 -glycolipid was not susceptible to endo-ß-N-acetylhexosaminidase as has been described by Tarentino et al Ref. 30 ). 'l'he result of the successive degradation through various hydrolases as described above, and through carbohydrate analysis of intact H3-glycolipids, clearly indicated the presence of 2 moles of fucose per glucosylceramide, Both fucosyl residues as well as two of the additional four galactosyl residues, were easily destroyed by periodate oxydation under controlled oxidation conditions (Hakamori et al Ref. 25) , suggesting the presence of two H-active carbohydrate chains linked to glycosylceramide by branching.
The concept of a branched structure was further supported by extensive methylation studies and through a characterization of partially methylated hexosaminitol and a partially 0-methylated 2-deoxy-2-N-methyl-acetamido-hexitol compound. Mass spectrometry of an enzyme degraded permethylated product, as has already been described, was used to determine the brauehing point (Watanabe et al Ref. 23) . Enzymatic degradation and methylation study do not identify the branching)point.
This distinction can be carried out by enzymatic hydrolysis combined with total mass spectrometry of the enzyme-degraded c~pound, after methylation and reduction (Karlsson, Ref. 28) . However, the original method was modified in the purification of permethylated compound and in the use of sodium bi~.(2-methoxyethoxy)aluminum hydride for reduction. The glycolipids were permethylated (Ref. 26); permethylated glycolipid was isolated by chromatography on LH-20 column followed by thin-layer chromatography on silica gel G, developed with benzeneacetone (1:1 v/v). The permethylated glycolipid, eluted from the silica gel with acetone and evaporated under nitrogen in a Teflon-lined screw-capped Pyrex glass tube, was dissolved in 1 m1 of benzene, and to it 0.5 m1 of sodium bis(2-methyoxyethoxy)aluminum hydride ("Vitride", 70% in benzene, Eastman Kodak) was added. It was then heated at 80° for 2 hr. After cooling, 1 m1 of water and 0.1 N sodium hydroxide was added, shaken well, and centrifuged. The upper benzene layer was separated, and the lower layer was partitioned twice with benzene. The first benzene layer and the benzene extract from the lower phase were combined and evaporated to dryness. The dried residue was dissolved in 1 m1 of chloreform and shaken with 1 m1 of water. The chloreform layer was evaporated to dryness in a glass "direct-probe tube" first under nitrogen stream and then in vacuo over phosphorus pentoxide. The residue was subjected to direct probe mass spectrometry in the Finnigan quadrupole instrument.
B.r successive treatment of H3-glycolipid with a-L-fucosidase and with ß-galactosidase, H3-glycolipid was converted to a glycolipid with two terminal N-acetylglucosamines, which were characterized by having a streng precipitin reaction with wheat germ lectin and by giving 3,4,6-tri-O-methyl-2-deoxy-2-N-methylglucitol after methylation analysis. This compound could have either of the following structures, I or II. As shown in Fig. 1C , the enzyme-degraded compound derived from H3-g1yco1ipid gave on1y intensive mass with m/e 246 (and 266), but none at 450. This c1ear1y indicates that the compound shou1d have both G1cNAc termina1s branched at the penultimate hexose; name1y, the compound should have structure I rather than structure II. The mass spectra of an intact permethy1-ated and reduced H3-g1yco1ipid were characterized by the presence of m/e 189 and 393, which is derived from the terminal fucosy1 and fucosy1ga1actosy1 residue, respective1y (See Fig. 1D ). The structure of H3-g1yco1ipids was thus determined as having two identica1 H-active type-2 chains attached to a parag1oboside by ß1+3 and ß1+6 1inkages.
H3-g1yco1ipid showed I-antigen activity both in inhibition of I-hemagg1utination and in precipitin reaction. This is in striking centrast to H1-and H2-g1yco1ipids which had no Iactivity at al1 (Watanabe et Since blood group glycolipids were minor membrane components and only a small amount of fetal and new-born erythrocytes were available, the change of blood group glycolipids in fetal and new-born erythrocytes were studied by the following methods: (1) A-glycolipids were studied by cell-surface labeling with galactose oxidase and tritiated borohydride according to the method of Gahmberg and Hakomori (Ref. 46), followed by a preparation of membrane extraction, and by a preparation of long-chain neutral glycolipids. (2) H2-glycolipids and their degradation products were studied through reactions of erythrocytes and glycolipid fractions of tissues with antibodies directed against H3-glycolipid and its degradation product (Struc~ tures 2, 3, 4 see Fig. 3 ), The H3-glycolipid was degraded step-by-step with purified a-L-fucosidase, ß-galactosidase, and ß-N-acetylhexosaminidase. Paragloboside and its degradation product were also prepared. These degraded glycolipids were purified through thinlayer chromatography. Purified glycolipids were complexed with bovine serum albumin and immunized rabbits with a complete Fruend adjuvant. Anti-sera were purified by BSA-Sepharose column to eliminate anti-BSA,
6 ß-Gall-+-4ß-GlcNAcl-+-3ß-Gall-+-4ßGlc-+-ceramide Fig, 3 Structure of H3-glycolipid and its degradation products to which antibodies were directed.
The ratios of the surface-labeled activities, new-born to adult erythrocytes of each Avariant (Aa, Ab, AC, and Ad) are shown in Table 5 , Aativities of each A-variant of new-born erythrocytes are expressed as % of adult erythrocytes. The labels of AC-and Ad-variants in fetal erythrocytes were significantly lower than those of adult erythrocytes. A similar experiment cannot be carried out for H-determinants, because they were not quantitatively labeled. Alternatively, the reactivities of erythrocytes to various antibodies. which are directed against H3 and its degradation products, were compared. The antibody which was directed against whole H3-~lycolipids (structtire 1), did not strongly cross-react to H1-and H2-structures (see Table 6 ). This indicates that the antibody recognizes a whole branched H-structure. This antibody strongly reacted to adult human erythrocytes, weakly reacted to cord erythrocytes, and did not react at all to fetal erythrocytes (Fig. 4A) . The higher reactivity of adult erythrocytes to anti-H3-glycolipids has been further confirmed through an absorption experiment, i·~· adult erythrocytes absorb about 8 times the quantity of anti-H3-antibodies than new-born erythrocytes absorb. 106 adult erythrocytes absorb almost all of the anti-H3 activity which was present in 50 jll of antisera (titer 1:128), whereas the supernatant of the same amount of antiserum, which was incubated with the same number of new-born erythrocytes, contained the anti-H3 antiserum. Inhibited partially by 3 ~g/50 ~1 *Determined by 3-hemagglutination doses of anti-H3 glycolipid rabbit antisera (purified by NSA-column) and in the presence of two times weight of cholesterol and lecithin.
The difference in reaction to an anti-H3 antibody between adult and fetal erythrocytes, became greater after trypsin treatment of erythrocytes, !·~· enhanced reaction of adult erythrocytes after trypsin treatment, and only a slight increase of cord erythrocytes (see Fig. 4A ). The agglutinability of both fetal and adult cells through anti-H3 antibodies are not thermosensitive as compared to the reactivity of erythrocytes as demonstrated by an anti-! antibody. In striking contrast, antibodies directed against the core structures of H3, such as structure 2 and 4 (see Fig. 3 ), reacted more strongly to fetal and/or cord erythrocytes than to adult erythrocytes (Fig. 4A) . The hemagglutination caused by these antibodies was extremely thermosensitive and completely disappeared at 37° C (Fig. 4B) , and intensified at 0-4° C (Fig. 4A) .. The agglutinability of erythrocytes by antibodies directed against structure 2 and 4 was completely reversible between high and low temperatures. There was a clear difference of agglutinability between fetal, new-born, and adult erythrocytes caused by anti-structure 4, 3 and 2 antibodies, however, this difference was not as remarkable as the agglutinability caused by an anti-structure 1 antibody (see Fig. 4A compared to 4B). Both adult and fetal erythrocytes intensified their reaction through protease treatment.
RECIPROCALS OF THE DIWTION OF PURIFIED ANTISERA
In using the antibodies which were directed against structures 1, 2, and 4, camparisans were made between the complement fixation reaction of glycolipids which were isolated from human intestinal mucosa, and glycolipids from human colon carcinoma. The results of only four cases are shown in Table 7 . A number of other cases were also determined (in total 16 cases). The average activity with anti-structure 4 antiserawas 1:160 for normal tissue and 1:750 for cancer tissue, respectively. While the antibody directed against structure 4 ( Fig. 3) showed a remarkable differential reactivity between normal and tumor glycolipids, the antibodies directed against structure 1 and 2 showed a similar reactivity towards normal and tumor glycolipids. ' 1) The presence of four sets of glycolipid variante in human A-and 0-erythrocytes, respectively have been established. The glycolipids carrying A-determinants were termed Aa, Ab Ac, and Ad according to the complexity of the carrier carbohydrate chain in that order, Similarly, four sets of glycolipids with H-activity were found in 0-erythrocytes, they were termed H 1 , H2, H3 and H4 according to the order of their complexity of the carrier carbohydrate chain. Except for Ad-and,H4-glycolipid, their structures were established. These structures are characterized by having exclusively "type 2 chain". The structure of the carrier carbohydrate chains of H 1 , H2, H 3 and H4 is identical to that of Aa, Ab, AC and Ad, respectively. Thus, it is assumed that H1, H 2 , H3 and H4 are the precursors of Aa, Ab, AC and Ad, This idea has been assessed by conversion of H1 to Aa, and H2 to Ab, by a serum A-enzyme as first described by Kim et al (Ref. 49) .
2) A possible molecular development of blood group carrier carbohydrate chains during ontogenesis has been suggested by the change of the proportion of various variante in erythrocytes, The highly complex variante of blood group glycolipids, such as Ac and H3, were lower in new-born than in adult erythrocytes and virtually absent in fetal erythrocytes, The low reactivity (agglutinability) of fetal/or new-born erythrocytes to anti-H3 glycolipids was not enhanced by protease treatment, This indicated that an H 3 -structure was absent or very low in fetal/er new-born erythrocytes. In fact, the cell surface-labeling experiment indicated that the concentration of an AC-structure, which is a branched analog of H3-erythrocytes, was significantly lower in new-born erythrocytes as compared to adult erythrocytes. In striking contrast, the structures corresponding to the precursors of blood group glycolipids were detected by immunological reaction in appreciable quantity in fetal and newborn erythrocytes, whereas, such reactions, due to the precursors, were less active in adult erythrocytes. This is particularly remarkable for the structure 4, the first amino sugar containing precursor for synthesizing a series of compounds, which led to blood group chains including the H3-structure. According to definition (Ref. 50) the property of the anti-H3 glycolipid behaved like that of anti-! antibody although thermosensitivity of hemagglutination caused by anti-H3 was not as remarkable as that displayed by anti-I. Whereas, the reactivity of antibodies which were directed against structures 2, 3, and 4 was by definition similar to the reactivity of erythrocytes displayed by anti-i, and was characterized by thermosensitivity as well.
The result of these studies suggests that step-by-step elongation and arborization of complex glycolipids such as Ac-and H3-chains may take place during the development and the appearance of a definite structure in the red blood cell membrane is not known and further extensive studies are required,
A remarkable difference between the reaction of glycolipids in human intestinal tumors and the reaction of normal intestinal mucosa was demonstrated by the antibody which was directed against structure 4, This difference was not observed with other antibodies, anti-structures 1, 2 and 3. It may be that structure 4 is present in greater quantity in tumor tissue than in normal mucosa tissue. In some cases, reaction against H3 was slightly higher in normal tissue than in tumor tissue. It is plausible that an accumulation of structure 4, i·~· ß-GlcNAcl+3ßGalR in tumor tissue results as a consequence of a blocked or inhibited synthesis of blood group chains. A similar accumulation of precursor glycolipids, in relation to a blocked synthesis of higher glycolipids, has been. exemplified in· many cases of transformed cell systems in vitro (Ref. 51, 52) . It has been clearly demonstrated in this study, however, that elongation and arborization of carbohydrate chains in h~ erythrocyte membranes are associated with ontogenic development. On the other hand, the development of carbohydrate chains in gastrointestinal mucosa is modified or blocked by an accumulation of one of the precursors in intestinal tumors,
The present study is, however, limited to adult, new-born, and fetal erythrocytes, colon mucosa and colon tumors, Further extensive comparison of the carbohydrate chains in various tissues and their correlation to ontogenesis is obviously necessary. The change of a link between carbohydrate chains and the state of arborization associated with the process of ontogeny and oncogeny may indicate that the structural complexity of a carbohydrate chain will influence membrane fluidity through altered interaction with other components of membranes, HEFERENCES
